Levosimendan in Patients with Low Cardiac Output Syndrome After Cardiac Surgery: A Substudy of the Multicenter Randomized CHEETAH Trial
Vladimir Boboshko(Meshalkin National Medical Research Center), Alessandro Belletti(Vita-Salute San Raffaele University), Antonio Pisano(Vita-Salute San Raffaele University), Maria Grazia Calabró(Vita-Salute San Raffaele University), В. В. Ломиворотов(Meshalkin National Medical Research Center), Marco Comis(A. O. Ordine Mauriziano di Torino), Liudmila Lomivorotova(Meshalkin National Medical Research Center), Pavel Ruzankin(Sobolev Institute of Mathematics), Fabrizio Monaco(Vita-Salute San Raffaele University), Tiziana Bove(Ospedale Santa Maria della Misericordia di Udine), S. E. Khrushchev(Ministry of Health of the Russian Federation)
Cited by 1
Related Papers
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Tranexamic Acid in Patients Undergoing Noncardiac Surgery
|New England Journal of Medicine|2022|322
Levosimendan for Hemodynamic Support after Cardiac Surgery
|New England Journal of Medicine|2017|299
Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery
|New England Journal of Medicine|2019|274
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency
|Critical Care and Resuscitation|2020|229